Valley National Advisers Inc Sorrento Therapeutics, Inc. Transaction History

Valley National Advisers Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$7.41 - $10.99 $15,257 - $22,628	-2,059 Reduced 40.7%	3,000 $23,000
Q1 2021 May 07, 2021	SELL	$7.03 - $16.51 $21,090 - $49,530	-3,000 Reduced 37.23%	5,059 $42,000
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $19,676 - $60,016	3,189 Added 65.48%	8,059 $89,000
Q2 2020 Aug 10, 2020	BUY	$1.73 - $6.76 $1,159 - $4,529	670 Added 15.95%	4,870 $31,000
Q1 2020 May 13, 2020	BUY	$1.57 - $4.76 $1,570 - $4,760	1,000 Added 31.25%	4,200 $8,000

Q3 2019 Nov 12, 2019	BUY	$2.05 - $2.69 $6,559 - $8,608	3,200 New	3,200 $7,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Valley National Advisers Inc with notifications on news.